Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Rapid Test Kit Detects Dengue Antibodies in Saliva

By LabMedica International staff writers
Posted on 09 Feb 2015
A paper-based disposable device has been developed that will allow dengue-specific antibodies to be detected easily from saliva within 20 minutes and the device is currently undergoing further development.

Paper-based immunoassays, usually in the form of lateral flow tests, are currently the standard platform for home diagnostics. More...
However, conventional lateral tests are often complicated by severe nonspecific adsorption of detector particles when applied to test samples containing salivary fluid.

Scientists at the Institute of Bioengineering and Nanotechnology (The Nanos; Singapore) developed a stacking flow device consisting of a test strip, a sample pad, a reagent pad, an absorbent pad, and a flow regulator. The sample and reagent pads were made of glass fiber, and the absorbent pad was made of cellulose (Merck Millipore, Billerica, Massachusetts, USA). The nitrocellulose test strip was cut into the required dimensions manually with a roller cutter. The detection of dengue-specific immunoglobulin G (IgG) was conducted using the liquid conjugate approach. The liquid conjugate was composed of protein G-conjugated 40 nm gold nanoparticles.

In the device, different flow paths are created for samples and reagents through a multiple stacked system. This allows the saliva sample to flow separately through a fiber glass matrix, which removes the substances that would interfere with the nanoparticle-based sensing system before it mixes with the sensor nanoparticles. The device’s configuration also helps to regulate the flow in the test strip, generating uniform test lines for more accurate results. The stacking flow immunoassay platform requires only one user activation step: both the sample and reagents are added at the same time in a single step. Both the sample and reagents react and flow concurrently in the test strip. The single-step procedure significantly improved the ease of usage of the test kit. The study was published on January 12, 2015, in the journal Lab on a Chip.

Related Links:

Institute of Bioengineering and Nanotechnology
Merck Millipore  



Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Verification Panels for Assay Development & QC
Seroconversion Panels
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
Gold Member
Parainfluenza Virus Test
PARAINFLUENZA ELISA
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.